Béguin, Jérémy
Gantzer, Murielle
Farine, Isabelle
Foloppe, Johann
Klonjkowski, Bernard
Maurey, Christelle
Quéméneur, Éric
Erbs, Philippe
Article History
Received: 12 November 2020
Accepted: 11 January 2021
First Online: 26 January 2021
Competing interests
: J.B., M.G., I.F., J.F., E.Q., and P.E. were employees of Transgene SA when the work was performed. Transgene SA is a publicly traded French biopharmaceutical company, with Institut Merieux as the major shareholder. The authors declare no other competing interests. J.B. is recipient of an Industrial Training Convention for Research (CIFRE) doctoral fellowship (2017/0266).